Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lissoni

Showing results (251-260 of 287) with videos related to

Pageof 29
Sort By:
European Journal of Cancer & Clinical Oncology|August 1, 1987
Effects of radical mastectomy on prolactin blood levels in patients with breast cancerS Barni, P Lissoni, F Paolorossi, et al.
La Radiologia Medica|October 1, 1987
[Concomitant therapy with cisplatin and radiotherapy in locally advanced tumors of the cervico-facial area]A Colombo, S Crispino, S Barni, et al.
Tumori|December 31, 1992
Neuroimmunotherapy with subcutaneous low-dose interleukin-2 and the pineal hormone melatonin as a second-line treatment in metastatic colorectal carcinomaS Barni, P Lissoni, M Cazzaniga, et al.
Journal of Biological Regulators and Homeostatic Agents|July 1, 1993
Effects of granulocyte-macrophage colony stimulating factor on soluble interleukin-2 receptor serum levels and their relation to neopterin and tumor necrosis factor-alpha in cancer patientsS Crispino, P Lissoni, A Ardizzoia, et al.
The International Journal of Biological Markers|May 23, 2006
Chromogranin A blood concentrations in relation to those of prolactin in hormone-refractory metastatic prostate cancer: possible existence of two independent mechanisms responsible for endocrine resistanceP Lissoni, P Viganò, A Podraska, et al.
Cancer|March 15, 1993
In vitro modulatory effects of interleukin-3 on macrophage activation induced by interleukin-2P Lissoni, S Pittalis, F Brivio, et al.
Tumori|October 31, 1987
Clinical study of melatonin in untreatable advanced cancer patientsP Lissoni, S Barni, G Tancini, et al.
The Journal of Nuclear Medicine and Allied Sciences|October 1, 1990
[Anti-tumor immune response in patients with colorectal carcinoma. Pre- and postoperative evaluation]F Brivio, P Lissoni, G M Rossi, et al.
Oncology|January 1, 1992
Randomized study with the pineal hormone melatonin versus supportive care alone in advanced nonsmall cell lung cancer resistant to a first-line chemotherapy containing cisplatinP Lissoni, S Barni, A Ardizzoia, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|April 1, 1995
[Lymphocyte levels before treatment with subcutaneous interleukin-2 and during maintenance treatment in relation to the clinical efficacy in metastatic renal carcinoma]M G Viganò, P Lissoni, S Barni, et al.
Pageof 29

Showing results (251-260 of 287) with videos related to

Sort By:
Pageof 29
European Journal of Cancer & Clinical Oncology|August 1, 1987
Effects of radical mastectomy on prolactin blood levels in patients with breast cancerS Barni, P Lissoni, F Paolorossi, et al.
La Radiologia Medica|October 1, 1987
[Concomitant therapy with cisplatin and radiotherapy in locally advanced tumors of the cervico-facial area]A Colombo, S Crispino, S Barni, et al.
Tumori|December 31, 1992
Neuroimmunotherapy with subcutaneous low-dose interleukin-2 and the pineal hormone melatonin as a second-line treatment in metastatic colorectal carcinomaS Barni, P Lissoni, M Cazzaniga, et al.
Journal of Biological Regulators and Homeostatic Agents|July 1, 1993
Effects of granulocyte-macrophage colony stimulating factor on soluble interleukin-2 receptor serum levels and their relation to neopterin and tumor necrosis factor-alpha in cancer patientsS Crispino, P Lissoni, A Ardizzoia, et al.
The International Journal of Biological Markers|May 23, 2006
Chromogranin A blood concentrations in relation to those of prolactin in hormone-refractory metastatic prostate cancer: possible existence of two independent mechanisms responsible for endocrine resistanceP Lissoni, P Viganò, A Podraska, et al.
Cancer|March 15, 1993
In vitro modulatory effects of interleukin-3 on macrophage activation induced by interleukin-2P Lissoni, S Pittalis, F Brivio, et al.
Tumori|October 31, 1987
Clinical study of melatonin in untreatable advanced cancer patientsP Lissoni, S Barni, G Tancini, et al.
The Journal of Nuclear Medicine and Allied Sciences|October 1, 1990
[Anti-tumor immune response in patients with colorectal carcinoma. Pre- and postoperative evaluation]F Brivio, P Lissoni, G M Rossi, et al.
Oncology|January 1, 1992
Randomized study with the pineal hormone melatonin versus supportive care alone in advanced nonsmall cell lung cancer resistant to a first-line chemotherapy containing cisplatinP Lissoni, S Barni, A Ardizzoia, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|April 1, 1995
[Lymphocyte levels before treatment with subcutaneous interleukin-2 and during maintenance treatment in relation to the clinical efficacy in metastatic renal carcinoma]M G Viganò, P Lissoni, S Barni, et al.
Pageof 29